{"id":"https://openalex.org/W4389028709","doi":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2","title":"Role of MAPKs and NF\u03baB in Tributyltin\u2010stimulated Interleukin 1 Beta Secretion and Production from Human Immune Cells","display_name":"Role of MAPKs and NF\u03baB in Tributyltin\u2010stimulated Interleukin 1 Beta Secretion and Production from Human Immune Cells","publication_year":2017,"publication_date":"2017-04-01","ids":{"openalex":"https://openalex.org/W4389028709","doi":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.31.1_supplement.615.2","doi":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081127735","display_name":"Mariam Boules","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75256744","display_name":"Tennessee State University","ror":"https://ror.org/01fpczx89","country_code":"US","type":"education","lineage":["https://openalex.org/I75256744"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariam Boules","raw_affiliation_strings":["Tennessee State University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee State University, Nashville, TN","institution_ids":["https://openalex.org/I75256744"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047923297","display_name":"Shyretha D. Brown","orcid":"https://orcid.org/0000-0002-0968-2349","observed_orcids":["https://orcid.org/0000-0002-0968-2349"]},"institutions":[{"id":"https://openalex.org/I75256744","display_name":"Tennessee State University","ror":"https://ror.org/01fpczx89","country_code":"US","type":"education","lineage":["https://openalex.org/I75256744"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shyretha Brown","raw_affiliation_strings":["Tennessee State University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee State University, Nashville, TN","institution_ids":["https://openalex.org/I75256744"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090757520","display_name":"Margaret M. Whalen","orcid":"https://orcid.org/0000-0002-1511-9181","observed_orcids":["https://orcid.org/0000-0002-1511-9181"]},"institutions":[{"id":"https://openalex.org/I75256744","display_name":"Tennessee State University","ror":"https://ror.org/01fpczx89","country_code":"US","type":"education","lineage":["https://openalex.org/I75256744"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Whalen","raw_affiliation_strings":["Tennessee State University, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee State University, Nashville, TN","institution_ids":["https://openalex.org/I75256744"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I75256744"],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35865825,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","score":0.07209999859333038,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.06729999929666519,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tributyltin","display_name":"tributyltin","score":1.0},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.878000020980835},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9570000171661377},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.8809999823570251},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9620000123977661},{"id":"https://openalex.org/keywords/jnk","display_name":"JNK","score":0.9860000014305115},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.7139999866485596},{"id":"https://openalex.org/keywords/endocrine-disruptors","display_name":"endocrine disruptors","score":0.7260000109672546},{"id":"https://openalex.org/keywords/mek1-2-inhibition","display_name":"MEK1/2 inhibition","score":0.7570000290870667},{"id":"https://openalex.org/keywords/jnk-inhibition","display_name":"JNK inhibition","score":0.8679999709129333},{"id":"https://openalex.org/keywords/nf-kappab-inhibition","display_name":"NF-\u03baB inhibition","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C2779078112","wikidata":"https://www.wikidata.org/wiki/Q13462192","display_name":"Tributyltin","level":2,"score":0.7643023729324341},{"id":"https://openalex.org/C49039625","wikidata":"https://www.wikidata.org/wiki/Q84230","display_name":"Secretion","level":2,"score":0.7392899394035339},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6330722570419312},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6253223419189453},{"id":"https://openalex.org/C51551487","wikidata":"https://www.wikidata.org/wiki/Q2043632","display_name":"p38 mitogen-activated protein kinases","level":4,"score":0.5689524412155151},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5497470498085022},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4843374490737915},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.44239819049835205},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.43837684392929077},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4201952815055847},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.4110432267189026},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3691336214542389},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3662447929382324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34806710481643677},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3310568332672119},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26624736189842224},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.21218961477279663},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.20219001173973083},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20068371295928955},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11396545171737671},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10214346647262573},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.31.1_supplement.615.2","doi":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.31.1_supplement.615.2","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000916201","display_name":"(3 of 3) MMC, VICC & TSU: Partners in Eliminating Cancer Disparities","funder_award_id":"U54CA163066","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389022863","https://openalex.org/W1744514437","https://openalex.org/W2809827091","https://openalex.org/W3017385948","https://openalex.org/W4389028597","https://openalex.org/W964430230","https://openalex.org/W1498715928","https://openalex.org/W3170693318","https://openalex.org/W3173485808","https://openalex.org/W4223638006"],"abstract_inverted_index":{"Tributyltin":[0],"(TBT)":[1],"contaminates":[2],"the":[3,28,38,73,112,115,145,196,202,211,237,250],"environment":[4],"due":[5],"to":[6,71,132,163,165,262],"its":[7],"many":[8],"uses":[9],"and":[10,36,48,61,119,121,129,171,184,204,229,239,264],"has":[11],"been":[12,69],"found":[13],"in":[14,91,123,126,136,218,226,232,252,257],"human":[15,32,55,92,258],"blood":[16,93,103],"samples":[17],"at":[18],"levels":[19,65,131,187,225],"as":[20,22],"high":[21],"261":[23],"nM.":[24],"TBT":[25,82,166,263],"interferes":[26],"with":[27,144],"lytic":[29],"function":[30],"of":[31,40,66,75,84,98,114,139,168,178,199,254],"natural":[33],"killer":[34],"lymphocytes":[35],"alters":[37],"secretion":[39,97,128,198,219,253],"interleukin":[41],"1":[42],"beta":[43],"(IL\u20101\u03b2),":[44],"Interferon":[45],"gamma":[46],"(IFN\u03b3)":[47],"tumor":[49],"necrosis":[50],"factor":[51],"alpha":[52],"(TNF\u03b1)":[53],"from":[54,100],"leukocytes.":[56],"IL\u20101\u03b2":[57,67,99,127,179,200,255],"regulates":[58],"cellular":[59],"growth":[60],"immune":[62,259],"responsiveness.":[63],"Elevated":[64],"have":[68],"shown":[70],"increase":[72,231],"invasiveness":[74],"tumors.":[76],"Our":[77],"recent":[78],"studies":[79],"showed":[80],"that":[81,88,195,245],"exposures":[83],"5\u201325":[85],"nM":[86,173],"(levels":[87],"are":[89,220,267],"seen":[90,256],"samples)":[94],"caused":[95],"increased":[96,223,246],"monocyte\u2010depleted":[101],"peripheral":[102],"mononuclear":[104],"cells":[105,228,260],"(MD\u2010PBMCs).":[106],"In":[107],"this":[108,230],"study":[109],"we":[110],"examine":[111],"roles":[113],"MAPKs,":[116],"(ERK1/2,":[117],"p38,":[118],"JNK)":[120],"NF\u03baB":[122,156,212],"TBT\u2010induced":[124,137,197],"increases":[125,217,251,266],"intracellular":[130,185],"assess":[133],"their":[134],"role":[135],"production":[138,234,248],"IL\u20101\u03b2.":[140],"MD\u2010PBMCs":[141],"were":[142,188],"treated":[143],"MEK1/2":[146],"inhibitor":[147,150,153,157],"PD98059,":[148],"p38":[149,205,240],"SB202190,":[151],"JNK":[152,214],"BI78D3":[154],"or":[155,213,274],"BAY":[158],"11\u20107085":[159],"for":[160,174],"1h":[161],"prior":[162],"exposure":[164],"concentrations":[167],"25,":[169],"10,":[170],"5":[172],"24":[175],"h.":[176],"Secretion":[177],"was":[180],"measured":[181],"using":[182,190],"ELISA":[183],"protein":[186,224,233,247],"monitored":[189],"western":[191],"blot.":[192],"Results":[193],"indicated":[194],"requires":[201],"ERK1/2":[203,238],"pathways.":[206,215,241],"But":[207],"does":[208],"not":[209],"require":[210],"The":[216],"accompanied":[221],"by":[222,278],"TBT\u2010exposed":[227],"also":[235],"utilized":[236],"These":[242],"data":[243],"suggest":[244],"accompanies":[249],"exposed":[261],"these":[265],"dependent":[268],"on":[269],"MAPK":[270],"pathway":[271],"activation.":[272],"Support":[273],"Funding":[275],"Information":[276],"Supported":[277],"NIH":[279],"grant":[280],"U54CA163066.":[281]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2023-11-27T00:00:00"}